Depreciation of G1 Therapeutics, Inc. from 31 Dec 2015 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
G1 Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2015 to 30 Jun 2024.
  • G1 Therapeutics, Inc. Depreciation for the quarter ending 30 Jun 2024 was $121,000, a 6.9% decline year-over-year.
  • G1 Therapeutics, Inc. Depreciation for the twelve months ending 30 Jun 2024 was $881,000, a 64% increase year-over-year.
  • G1 Therapeutics, Inc. annual Depreciation for 2022 was $530,000, a 13% increase from 2021.
  • G1 Therapeutics, Inc. annual Depreciation for 2021 was $469,000, a 19% decline from 2020.
  • G1 Therapeutics, Inc. annual Depreciation for 2020 was $582,000, a 63% increase from 2019.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

G1 Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $881,000 $121,000 -$9,000 -6.9% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $890,000 $120,000 -$12,000 -9.1% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $902,000 $513,000 +$376,000 +274% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
Q3 2023 $526,000 $127,000 -$12,000 -8.6% 01 Jul 2023 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $538,000 $130,000 -$9,000 -6.5% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $547,000 $132,000 +$17,000 +15% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q4 2022 $530,000 $137,000 +$23,000 +20% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $507,000 $139,000 +$22,000 +19% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $485,000 $139,000 +$21,000 +18% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $464,000 $115,000 -$5,000 -4.2% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $469,000 $114,000 -$45,000 -28% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $514,000 $117,000 -$28,000 -19% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $542,000 $118,000 -$40,000 -25% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $582,000 $120,000 -$39,000 -25% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $621,000 $159,000 +$18,000 +13% 01 Oct 2020 31 Dec 2020 10-Q 05 May 2021 2021 Q1
Q3 2020 $603,000 $145,000 +$59,000 +69% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $544,000 $158,000 +$93,000 +143% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $451,000 $159,000 +$95,000 +148% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $356,000 $141,000 +$81,000 +135% 01 Oct 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
Q3 2019 $275,000 $86,000 +$38,000 +79% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $237,000 $65,000 +$30,000 +86% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $207,000 $64,000 +$32,000 +100% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $175,000 $60,000 +$30,000 +100% 01 Oct 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
Q3 2018 $145,000 $48,000 +$21,000 +78% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $124,000 $35,000 +$15,000 +75% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $109,000 $32,000 +$20,000 +167% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $89,000 $30,000 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
Q3 2017 $27,000 +$9,000 +50% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $20,000 +$7,000 +54% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $12,000 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q3 2016 $18,000 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $13,000 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2

G1 Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $530,000 +$61,000 +13% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $469,000 -$113,000 -19% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $582,000 +$226,000 +63% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $356,000 +$181,000 +103% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $175,000 +$86,000 +97% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $89,000 +$22,000 +33% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $67,000 +$25,000 +60% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $42,000 01 Jan 2015 31 Dec 2015 10-K 21 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.